Cara Therapeutics, Inc. (CARA) Q4 2021 Earnings Call

Investor webinar replay

Meeting Overview The meeting was a conference call held by CARA Therapeutics to discuss their financial results for the fourth quarter and full year of 2021. Key updates included the launch preparations for their product, Korsuva Injection, and advancements in their clinical programs. Key Discussion Points - Introduction of the conference call and participants. - Overview of CARA Therapeutics' corporate progress and financial results. - Forward-looking statements regarding commercialization and regulatory approvals for Korsuva Injection. - Updates on the launch preparations for Korsuva Injection, including market potential and reimbursement status. - Discussion of strategic priorities, including advancing oral Korsuva programs and expanding clinical utility in other therapeutic areas. - Upcoming virtual R&D day scheduled for March 11 to provide further details on clinical trials. Decisions Made - No explicit decisions recorded. Action Items & Next Steps - [Unassigned] : Provide more...

Watch the replay

Replay transcript excerpt

[Speaker identities could not be resolved; generic labels used] [00:00] Speaker 1: Good afternoon. My name is Andrew, and I will be your conference facilitator. [00:04] Speaker 1: I would like to welcome everyone to the CARA Therapeutics [00:07] Speaker 1: 4th 0.25 2021 [00:08] Speaker 1: Financial Results and Update Conference Call. [00:12] Speaker 1: All lines have been placed on mute to avoid any background noise. [00:16] Speaker 1: After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time simply press star and the number 1 on your telephone keypad. [00:26] Speaker 1: If you would like to withdraw your question press the pound key. [00:30] Speaker 1: Please be advised that this call is being recorded. [00:34] Speaker 1: I would now like to introduce [00:36] Speaker 1: Iris Francesconi, [00:38] Speaker 1: Interim Head of Investor Relations [00:40] Speaker 1: from CARE Therapeutics. [00:41] Speaker 1: Ms. Francesconi, you may begin your call. [00:46] Speaker 2: Thank you, Andrew, and good afternoon. [00:48] Speaker 2: Just after market close today, we issued a press release detailing our corporate progress and financial results for the 4th 0.25 and full year 2021. [00:58] Speaker 2: Press release can be found on our website at www.caratherapeutics.com. [01:04] Speaker 2: You may also listen to a live webcast and replay of today's call on the investor section of the website. [01:11] Speaker 2: Participating [01:12] Speaker 2: in today's call are Chris Posner, [01:14] Speaker 2: CARES President and Chief Executive Officer, [01:17] Speaker 2: Tom Riley, CARES Chief Financial Officer, [01:20] Speaker 2: and Joanna Goncalves, [01:21] Speaker 2: CARES Chief Medical Officer. [01:24] Speaker 2: Before we b...